Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
388.5 CHF | -1.89% |
|
-4.67% | +27.89% |
12/06 | German Pharmaceutical Medac Picks Ypsomed Autoinjector for Methotrexate Pen Relaunch | MT |
22/05 | Ypsomed Holding AG Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.89% | 610.56Cr | |
-5.52% | 18TCr | |
-3.19% | 10TCr | |
-4.14% | 6.75TCr | |
-6.00% | 4.64TCr | |
+15.49% | 4.67TCr | |
+4.77% | 4.07TCr | |
+22.10% | 3.16TCr | |
-8.53% | 2.35TCr | |
+11.75% | 2.43TCr |
- Stock Market
- Equities
- YPSN Stock
- News Ypsomed Holding AG
- Ypsomed Reports Higher FY24 Net Profit, Sales